← Open Payments lookup

MICHAEL HOLMAN: Open Payments

NPI 1073576070 · KOSCIUSKO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$764 in 36 payments from 8 companies in 2025. Trend: 2023 $1,562 · 2024 $1,557 · 2025 $764

Food & beverage: $764
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$283
Novo Nordisk Inc11$181
PFIZER INC.5$92
ABBVIE INC.4$65
Otsuka America Pharmaceutical, Inc.2$60
GlaxoSmithKline, LLC.2$32
Averitas Pharma Inc.1$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24

Products named: FARXIGA, Ozempic, BREZTRI, REXULTI, PREVNAR 20, Rybelsus, UBRELVY, NURTEC ODT.

Industry payments across MS — which companies pay providers there.